- Home
- KOPN vs ANVS Comparison
KOPN vs ANVS Comparison
Compare KOPN & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- ANVS
- Stock Information
- Founded
- KOPN 1984
- ANVS 2008
- Country
- KOPN United States
- ANVS United States
- Employees
- KOPN N/A
- ANVS N/A
- Industry
- KOPN Semiconductors
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- KOPN Technology
- ANVS Health Care
- Exchange
- KOPN Nasdaq
- ANVS Nasdaq
- Market Cap
- KOPN 282.1M
- ANVS 31.2M
- IPO Year
- KOPN 1992
- ANVS 2020
- Fundamental
- Price
- KOPN $1.31
- ANVS $1.65
- Analyst Decision
- KOPN Strong Buy
- ANVS Strong Buy
- Analyst Count
- KOPN 4
- ANVS 5
- Target Price
- KOPN $2.63
- ANVS $37.00
- AVG Volume (30 Days)
- KOPN 2.4M
- ANVS 435.2K
- Earning Date
- KOPN 05-13-2025
- ANVS 03-31-2025
- Dividend Yield
- KOPN N/A
- ANVS N/A
- EPS Growth
- KOPN N/A
- ANVS N/A
- EPS
- KOPN N/A
- ANVS N/A
- Revenue
- KOPN $44,266,305.00
- ANVS N/A
- Revenue This Year
- KOPN $21.20
- ANVS N/A
- Revenue Next Year
- KOPN $13.55
- ANVS N/A
- P/E Ratio
- KOPN N/A
- ANVS N/A
- Revenue Growth
- KOPN 0.60
- ANVS N/A
- 52 Week Low
- KOPN $0.56
- ANVS $1.53
- 52 Week High
- KOPN $2.33
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- KOPN 43.13
- ANVS 24.29
- Support Level
- KOPN $1.16
- ANVS $1.53
- Resistance Level
- KOPN $1.40
- ANVS $1.77
- Average True Range (ATR)
- KOPN 0.15
- ANVS 0.16
- MACD
- KOPN -0.01
- ANVS 0.09
- Stochastic Oscillator
- KOPN 42.86
- ANVS 18.18
Stock Price Comparison Chart: KOPN vs ANVS
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.